Skip to main content
Premium Trial:

Request an Annual Quote

Advion, Agilent to Co-Market Mass Spec Technologies

NEW YORK (GenomeWeb News) – Advion Biosystems and Agilent Technologies jointly announced today that they have signed a co-marketing pact covering the promotion of Advion’s TriVersa NanoMate system with Agilent’s mass spectrometers.
Advion’s NanoMate is an automated fraction collection and nanoelectrospray system that connects to the inlet of a mass spectrometer. The firms said that the NanoMate differs from Agilent’s 1200 Series HPLC-Chips in that it operates at capillary and microflow rates needed for fraction collection, “enabling collection of individual peaks for highly sensitive infusion MS analysis,” while Agilent’s system provides LC-MS at nanoflow rates that are “well-suited to applications where the amount of sample available is limited.”
The firms will co-market the TriVersa NanoMate with Agilent mass specs with each company responsible for their respective products. Advion will also sell the bracket to interface the NanoMate with the Agilent mass specs. The partners also will co-promote the products at industry tradeshows and conferences.
Ken Miller, global senior marketing manager for mass spectrometry at Agilent, said that Advion’s system will be “very complementary” to Agilent’s HPLC-Chip technology. “The TriVersa system offers some added capabilities such as fraction collection of peaks of interest and should prove to be very useful for protein characterization and biomarker discovery experiments,” he said in a statement.
Financial terms if the agreement were not disclosed.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.